Factors predicting the prognosis of oral alendronate-related osteonecrosis of the jaws: a 4-year cohort study. [electronic resource]
- Head & neck Dec 2013
- 1787-95 p. digital
Publication Type: Journal Article
1097-0347
10.1002/hed.23235 doi
Adult Aged Aged, 80 and over Alendronate--adverse effects Alkaline Phosphatase--blood Amoxicillin--therapeutic use Amoxicillin-Potassium Clavulanate Combination--therapeutic use Anti-Bacterial Agents--therapeutic use Biomarkers--blood Bisphosphonate-Associated Osteonecrosis of the Jaw--pathology Bone Density Conservation Agents--adverse effects Bone Remodeling Chlorhexidine--therapeutic use Clindamycin--therapeutic use Cohort Studies Collagen Type I--blood Debridement Female Humans Male Middle Aged Mouthwashes--therapeutic use Multivariate Analysis Osteoporosis--drug therapy Peptides--blood Prognosis Retrospective Studies